tetra(2-N-methylpyridyl)porphine: binds with human serum albumin
ID Source | ID |
---|---|
PubMed CID | 135431067 |
SCHEMBL ID | 450416 |
MeSH ID | M0160778 |
Synonym |
---|
2-tmpyp |
tetra(2-n-methylpyridyl)porphine |
pyridinium, 2,2',2'',2'''-(21h,23h-porphine-5,10,15,20-tetrayl)tetrakis(1-methyl- |
2,2',2'',2'''-(21h,23h-porphine-5,10,15,20-tetrayl)tetrakis(1-methylpyridinium) |
meso-tetra(2-n-methylpyridyl)porphine |
59728-89-1 |
SCHEMBL450416 |
5,10,15,20-tetrakis(1-methylpyridin-1-ium-2-yl)-21,23-dihydroporphyrin |
Excerpt | Reference |
---|---|
" We defined new strategies aimed at treatment of mature established biofilms using photodynamic treatment (PDT) combined with chemotherapy or phagocytosis." | ( The effect of photodynamic treatment combined with antibiotic action or host defence mechanisms on Staphylococcus aureus biofilms. Di Poto, A; Provenza, G; Sbarra, MS; Speziale, P; Visai, L, 2009) |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |